Vishal Sikri reports a stock award at Myriad Genetics

By AlphaYouPublished Nov 10, 2026Form 4

Stocks in this disclosure

Reported activity

Sikri Vishal

Reporting filer

Vishal Sikri reports a stock award, not an open-market purchase or sale, in Myriad Genetics Inc. Form 4 filed Nov 9, 2026 lists 1 entry.

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Time-Based Stock Option (derivative)	Sikri Vishal	2026-11-06	A	Grant or award	53236	0	53,236	3 days	Filed terms security Title: Time-Based Stock Option id: F1 conversion Or Exercise Price: 5.92 id: F2 transaction Date: 2026-11-06 transaction Form Type: 4 transaction Code: A equity Swap Involved: 0 transaction Shares: 53236 transaction Price Per Share: 0 transaction Acquired Disposed Code: A exercise Date: 2029-11-06 expiration Date: 2036-11-06 underlying Security Title: Common Stock underlying Security Shares: 53236 shares Owned Following Transaction: 53236 direct Or Indirect Ownership: D

Owner: Sikri Vishal
Date: 2026-11-06
Code: A
Action: Grant or award
Quantity: 53236
Price: 0
Following holdings: 53,236
Reporting delay: 3 days
Filed terms and references: Filed terms
security Title: Time-Based Stock Option
id: F1
conversion Or Exercise Price: 5.92
id: F2
transaction Date: 2026-11-06
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Shares: 53236
transaction Price Per Share: 0
transaction Acquired Disposed Code: A
exercise Date: 2029-11-06
expiration Date: 2036-11-06
underlying Security Title: Common Stock
underlying Security Shares: 53236
shares Owned Following Transaction: 53236
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Sikri Vishal: EVP, Commercial.
F1: Represents a one-time non-qualified stock option granted as a retention award under the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan (the "Plan"). The option vests and becomes exercisable in full on November 6, 2029, subject to the Reporting Person's continued service through that date and the terms and conditions of the Plan and the applicable award agreement.
F2: The exercise price equals the closing price of the Issuer's common stock on November 6, 2026, the grant date.

Prepared automatically from public filing data. Report a correction.